What is Omeros's price / sales?

Omeros (OMER) reported price / sales of 9.5× in Q3 2021.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Omeros OMER Price / sales

Discontinued — last reported Q3 '21

Price / sales at other companies

Nektar TherapeuticsNKTR

37.1×+35.7×

ImmunomeIMNM

616.2×+563×

Arcus BiosciencesRCUS

11.5×+5.6×

Dianthus TherapeuticsDNTH

509×+334×

AnaptysBio, Inc.ANAB

6.9×+1.8×

Spyre Therapeutics, Inc.SYRE

1,993×+1,970×

Other financials

Income statement

See full

Revenue$9.9M—

Gross profit$29.7M—

Operating income-$40.9M-9.2%

Net income$56.1M+268%

EPS (diluted)-$0.59-20.4%

Balance sheet

See full

Cash & equivalents$1.9M-55.3%

Total debt$13.5M-30.3%

Total equity-$63.3M+70.3%

Total assets$286.2M+21.7%

Cash flow

See full

Operating cash flow-$14.5M+59.5%

CapEx--100%

Free cash flow-$14.5M+59.6%

Valuation

See full

Market cap$775.86M+313%

Profitability

See full

Gross margin98.9%—

Operating margin-181.8%—

Net margin-136.6%—

FCF margin-121.6%—

Returns & leverage

See full

Return on equity86.6%—

Debt / equity0.3×-1.1×

Current ratio3×+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

market cap/total revenue=9.5×

Based on the most recent quarter.

The official record: Omeros’s 10-Q, filed November 9, 2021, on SEC EDGAR. View the filing →

Ask your AI about Omeros's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Omeros's price / sales?: Omeros (OMER) reported price / sales of 9.5× in Q3 2021.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.